Regulation of toxin synthesis in Clostridium botulinum and Clostridium tetani

Toxicon

Volumn 75, Issue , 2013, Pages 90-100

  Connan, Chloé ^a   Denève, Cécile ^a   Mazuet, Christelle ^a   Popoff, Michel R ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Botulinum neurotoxin; Clostridium botulinum; Clostridium tetani; Regulation; Tetanus toxin

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN F; RNA; SIGMA FACTOR; SMALL REGULATORY RNA; TETANUS TOXIN; UNCLASSIFIED DRUG;

ANTP GENE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BONT GENE; BOTR GENE; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM SPOROGENES; CLOSTRIDIUM SUBTERMINALE; CLOSTRIDIUM TETANI; COMPLEX FORMATION; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENETIC TRANSCRIPTION; NONHUMAN; OPERON; PRIORITY JOURNAL; QUORUM SENSING; TETR GENE; TOXIN SYNTHESIS;

CLOSTRIDIA; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI;

BOTULINUM NEUROTOXIN; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; REGULATION; TETANUS TOXIN;

BACTERIAL PROTEINS; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM TETANI; DNA, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; GENETIC LOCI; OPERON; PLASMIDS; QUORUM SENSING; SIGMA FACTOR; TETANUS TOXIN; TRANS-ACTIVATORS;

EID: 84885326315     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2013.06.001     Document Type: Article

References (117)

1. Argaman L., Hershberg R., Vogel J., Bejerano G., Wagner E.G., Margalit H., Altuvia S. Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr. Biol. 2001, 11:941-950.
2. Artin I., Carter A.T., Holst E., Lovenklev M., Mason D.R., Peck M.W., Radstrom P. Effects of carbon dioxide on neurotoxin gene expression in nonproteolytic Clostridium botulinum Type E. Appl. Environ. Microbiol. 2008, 74:2391-2397.
3. Artin I., Mason D.R., Pin C., Schelin J., Peck M.W., Holst E., Radstrom P., Carter A.T. Effects of carbon dioxide on growth of proteolytic Clostridium botulinum, its ability to produce neurotoxin, and its transcriptome. Appl. Environ. Microbiol. 2010, 76:1168-1172.
4. Ba-Thein W., Lyristis M., Ohtani K., Nisbet I.T., Hayashi H. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens. J. Bacteriol. 1996, 178:2514-2520.
5. Barash J.R., Arnon S.S. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism. J. Clin. Microbiol. 2004, 42:1713-1715.
6. Bhandari M., Campbell K.D., Collins M.D., East A.K. Molecular characterization of the clusters of genes encoding the botulinum neurotoxin complex in Clostridium botulinum (Clostridium argentinense) type G and nonproteolytic Clostridium botulinum type B. Curr. Microbiol. 1997, 35:207-214.
7. Binz T., Kurazono H., Wille M., Frevert J., Wernars K., Niemann H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J. Biol. Chem. 1990, 265:9153-9158.
8. Bradshaw M., Dineen S.S., Maks N.D., Johnson E.A. Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC2916. Anaerobe 2004, 10:321-333.
9. Brüggemann H., Bäumer S., Fricke W.F., Wiezr A., Liesagang H., Decker I., Herzberg C., Martinez-Arias R., Henne A., Gottschalk G. The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1316-1321.
10. Brüggemann H., Gottschalk G. Insights in metabolism and toxin production from the complete genome sequence of Clostridium tetani. Anaerobe 2004, 10:53-68.
11. Brüggemann H., Wolher A., Mazuet C., Popoff M.R. Clostridium botulinum. Genomes of Food- and Water Borne Pathogens 2011, 185-212. ASM, Washington DC. P. Fratamico, Y. Liu, S. Kathariou (Eds.).
12. Brunger A.T., Rummel A. Receptor and substrate interactions of clostridial neurotoxins. Toxicon 2009, 54:550-560.
13. Carter A.T., Paul C.J., Mason D.R., Twine S.M., Alston M.J., Logan S.M., Austin J.W., Peck M.W. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 2009, 10:115.
14. Carter G.P., Purdy D., Williams P., Minton N.P. Quorum sensing in Clostridium difficile: analysis of a luxS-type signaling. J. Med. Microbiol. 2005, 54:119-127.
15. Chen Y., Indurthi D.C., Jones S.W., Papoutsakis E.T. Small RNAs in the genus Clostridium. MBio 2011, 2. e00340-00310.
16. Chen Y., Korkeala H., Aarnikunnas J., Lindstrom M. Sequencing the botulinum neurotoxin gene and related genes in Clostridium botulinum type E strains reveals orfx3 and a novel type E neurotoxin subtype. J. Bacteriol. 2007, 189:8643-8650.
17. Chen Y., Korkeala H., Linden J., Lindstrom M. Quantitative real-time reverse transcription-PCR analysis reveals stable and prolonged neurotoxin cluster gene activity in a Clostridium botulinum type E strain at refrigeration temperature. Appl. Environ. Microbiol. 2008, 74:6132-6137.
18. Cheung J.K., Awad M.M., McGowan S., Rood J.I. Functional analysis of the VirSR phosphorelay from Clostridium perfringens. PLoS One 2009, 4:e5849.
19. Cheung J.K., Keyburn A.L., Carter G.P., Lanckriet A.L., Van Immerseel F., Moore R.J., Rood J.I. The VirSR two-component signal transduction system regulates NetB toxin production in Clostridium perfringens. Infect. Immun. 2010, 78:3064-3072.
20. Connan C., Brueggemann H., Mazuet C., Raffestin S., Cayet N., Popoff M.R. Two-component systems are involved in the regulation of botulinum neurotoxin synthesis in Clostridium botulinum type a strain hall. PLoS One 2012, 7.
21. Cooksley C.M., Davis I.J., Winzer K., Chan W.C., Peck M.W., Minton N.P. Regulation of neurotoxin production and sporulation by a Putative agrBD signaling system in proteolytic Clostridium botulinum. Appl. Environ. Microbiol. 2010, 76:4448-4460.
22. Couesnon A., Raffestin S., Popoff M.R. Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. Microbiology 2006, 152:759-770.
23. Dineen S.S., Bradshaw M., Karasek C.E., Johnson E.A. Nucleotide sequence and transcriptional analysis of the type A2 neurotoxin gene cluster in Clostridium botulinum. FEMS Microbiol. Lett. 2004, 235:9-16.
24. Dover N., Barash J.R., Hill K.K., Detter J.C., Arnon S.S. Novel structural elements within the nonproteolytic Clostridium botulinum type F toxin gene cluster. Appl. Environ. Microbiol. 2011, 77:1904-1906.
25. Dupuy B., Mani N., Katayama S., Sonenshein A.L. Transcription activation of a UV-inducible Clostridium perfringens bacteriocin gene by a novel sigma factor. Mol. Microbiol. 2005, 55:1196-1206.
26. Dupuy B., Raffestin S., Matamouros S., Mani N., Popoff M.R., Sonenshein A.L. Regulation of toxin and bacteriocin gene expression in Clostridium by interchangeable RNA polymerase sigma factors. Mol. Microbiol. 2006, 60:1044-1057.
27. Dupuy B., Sonenshein A.L. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 1998, 27:107-120.
28. East A.K., Bhandari M., Hielm S., Collins M.D. Analysis of the botulinum neurotoxin type F gene clusters in proteolytic and nonproteolytic Clostridium botulinum and Clostridium baratii. Curr. Microbiol. 1998, 37:262-268.
29. East A.K., Bhandari M., Stacey J.M., Campbell K.D., Collins M.D. Organization and phylogenetic interrelationships of genes encoding components of the botulinum toxin complex in proteolytic Clostridium botulinum types A, B, and F: evidence of chimeric sequences in the gene encoding the nontoxic nonhemagglutinin component. Int. J. Syst. Bacteriol. 1996, 46:1105-1112.
30. Eberhard A. Inhibition and activation of bacterial luciferase synthesis. J. Bacteriol. 1972, 109:1101-1105.
31. Eklund M.W., Poysky F.T., Habig W.H. Bacteriophages and plasmids in Clostridium botulinum and Clostridium tetani and their relationship to production of toxins. Botulinum Neurotoxin and Tetanus Toxin 1989, 25-51. Academic Press, San Diego. L.L. Simpson (Ed.).
32. Ethapa T., Leuzzi R., Ng Y.K., Baban S.T., Adamo R., Kuehne S.A., Scarselli M., Minton N.P., Serruto D., Unnikrishnan M. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J. Bacteriol. 2013, 195:545-555. (Epub 02012 Nov 01921). 10.1128/JB.01980-01912.
33. Federle M.J., Bassler B.L. Interspecies communication in bacteria. J. Clin. Invest. 2003, 112:1291-1299.
34. Franciosa G., Ferreira J.L., Hatheway C.L. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J. Clin. Microbiol. 1994, 32:1911-1917.
35. Franciosa G., Maugliani A., Scalfaro C., Aureli P. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS One 2009, 4:e4829.
36. Galperin M.Y. Diversity of structure and function of response regulator output domains. Curr. Opin. Microbiol. 2010, 13:150-159. (Epub 2010 Mar 1011). 10.1016/j.mib.2010.1001.1005.
37. Galperin M.Y., Higdon R., Kolker E. Interplay of heritage and habitat in the distribution of bacterial signal transduction systems. Mol. Biosyst. 2010, 6:721-728.
38. Gao R., Mack T.R., Stock A.M. Bacterial response regulators: versatile regulatory strategies from common domains. Trends Biochem. Sci. 2007, 32:225-234. (Epub 2007 Apr 2012).
39. Gutierrez P., Li Y., Osborne M.J., Pomerantseva E., Liu Q., Gehring K. Solution structure of the carbon storage regulator protein CsrA from Escherichia coli. J. Bacteriol. 2005, 187:3496-3501.
40. Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J. Clin. Microbiol. 1985, 21:654-655.
41. Hassan K.A., Tetu S.G., Elbourne L.D., Johnson E.A., Paulsen I.T. Genome sequence of the group III Clostridium botulinum strain Eklund-c. Genome Announc. 2013, 1:e0004413. doi:0004410.0001128/genomeA.0000044-0004413.
42. Hassan S., Ohtani K., Wang R., Yuan Y., Wang Y., Yamaguchi Y., Shimizu T. Transcriptional regulation of hemO encoding heme oxygenase in Clostridium perfringens. J. Microbiol. 2010, 48:96-101.
43. Hauser D., Eklund M.W., Boquet P., Popoff M.R. Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes in Clostridium botulinum C468. Mol. Gen. Genet. 1994, 243:631-640.
44. Hauser D., Gibert M., Marvaud J.C., Eklund M.W., Popoff M.R. Botulinal neurotoxin C1 complex, Clostridial neurotoxin homology and genetic transfer in Clostridium botulinum. Toxicon 1995, 33:515-526.
45. Helmann J.D. The extracytoplasmic function (ECF) sigma factors. Adv. Microbial. Physiol. 2002, 46:47-110.
46. Henderson I., Whelan S.M., Davis T.O., Minton N.P. Genetic characterization of the botulinum toxin complex of Clostridium botulinum strain NCTC2916. FEMS Microbiol. Lett. 1996, 140:151-158.
47. Hill K.K., Smith T.J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr. Top Microbiol. Immunol. 2013, 364:1-20. 10.1007/1978-1003-1642-33570-33579_33571.
48. Hill K.K., Smith T.J., Helma C.H., Ticknor L.O., Foley B.T., Svensson R.T., Brown J.L., Johnson E.A., Smith L.A., Okinaka R.T., Jackson P.J., Marks J.D. Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J. Bacteriol. 2007, 189:818-832.
49. Hill K.K., Xie G., Foley B.T., Smith T.J., Munk A.C., Bruce D., Smith L.A., Brettin T.S., Detter J.C. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol. 2009, 7:66.
50. Hirst T.R. Biogenesis of cholera toxin and related oligomeric toxins. Bacterial Toxins and Virulence Factors in Disease 1995, 123-184. Marcel Dekker, New York. J. Moss, B. Iglewsski, M. Vaughan, A.T. Tu (Eds.).
51. Hundsberger T., Braun V., Weidmann M., Leukel P., Sauerborn M., von Eichel-Streiber C. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur. J. Biochem. 1997, 244:735-742.
52. Hutson R.A., Zhou Y., Collins M.D., Johnson E.A., Hatheway C.L., Sugiyama H. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J. Biol. Chem. 1996, 271:10786-10792.
53. Inoue K., Fujinaga Y., Watanabe T., Ohyama T., Takeshi K., Moriishi K., Nakajima H., Inoue K., Oguma K. Molecular composition of Clostridium botulinum type A progenitor toxins. Infect. Immun. 1996, 64:1589-1594.
54. Jacobson M.J., Lin G., Raphael B., Andreadis J., Johnson E.A. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl. Environ. Microbiol. 2008, 74:2778-2786.
55. Jovita M.R., Collins M.D., East A.K. Gene organization and sequence determination of the two botulinum neurotoxin gene clusters in Clostridium botulinum. Cur. Microbiol. 1998, 36:226-231.
56. Karlsson S., Burman L.G., Akerlund T. Suppression of toxin production in Clostridium difficile VPI10463 by amino acids. Microbiology 1999, 145:1683-1693.
57. Karlsson S., Dupuy B., Mukherjee K., Norin E., Burman L.G., Akerlund T. Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature. Infect. Immun. 2003, 71:1784-1793.
58. Klinkert B., Narberhaus F. Microbial thermosensors. Cell Mol. Life Sci. 2009, 66:2661-2676.
59. Kouguchi H., Suzuki T., Hasegawa K., Mutoh S., Watanabe T., Niwa K., Yoneyama T., Katoh Y., Ohyama T. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947. J. Microbiol. Methods 2006, 67:416-423. (Epub 2006 May 2024).
60. Kubota T., Yonekura N., Hariya Y., Isogai E., Isogai H., Amano K., Fujii N. Gene arrangement in the upstream region of Clostridium botulinum type E and Clostridium butyricum BL6340 progenitor toxin genes is different from that of other types. FEMS Microbiol. Lett. 1998, 158:215-221.
61. Lacy D.B., Stevens R.C. Sequence homology and structural analysis of the clostridial neurotoxins. J. Mol. Biol. 1999, 291:1091-1104.
62. Lee A.S., Song K.P. LuxS/autoinducer-2 quorum sensing molecule regulates transcriptional virulence gene expression in Clostridium difficile. Biochem. Biophys. Res. Commun. 2005, 335:659-666.
63. Li B., Qian X., Sarkar H.K., Singh B.R. Molecular characterization of type E Clostridium botulinum and comparison to other types of Clostridium botulinum. Biochim. Biophys. Acta 1998, 1395:21-27.
64. Lin G., Tepp W.H., Pier C.L., Jacobson M.J., Johnson E.A. Expression of the Clostridium botulinum A2 neurotoxin gene cluster proteins and characterization of the A2 complex. Appl. Environ. Microbiol. 2010, 76:40-47.
65. Lin W.J., Johnson E.A. Genome analysis of Clostridium botulinum type A by pulsed-field gel electrophoresis. Appl. Environ. Microbiol. 1995, 61:4441-4447.
66. Lindstrom M., Dahlsten E., Soderholm H., Selby K., Somervuo P., Heap J.T., Minton N.P., Korkeala H. Involvement of two-component system CBO0366/CBO0365 in the cold shock response and growth of group I (Proteolytic) Clostridium botulinum ATCC 3502 at low temperatures. Appl. Environ. Microbiol. 2012, 78:5466-5470.
67. Lövenklev M., Artin I., Hagberg O., Borch E., Holst E., Radström P. Quantitative interaction effects of carbon dioxide, sodium chloride, and sodium nitrite on neurotoxin gene expression in nonproteolytic Clostridium botulinum type B. Appl. Environ. Micrcobiol. 2004, 70:2928-2934.
68. Luquez C., Raphael B.H., Joseph L.A., Meno S.R., Fernandez R.A., Maslanka S.E. Genetic diversity among Clostridium botulinum strains harboring bont/A2 and bont/A3 genes. Appl. Environ. Microbiol. 2012, 78:8712-8718.
69. Luquez C., Raphael B.H., Maslanka S.E. Neurotoxin gene clusters in Clostridium botulinum type Ab strains. Appl. Environ. Microbiol. 2009, 75:6094-6101.
70. Ma M., Vidal J., Saputo J., McClane B.A., Uzal F. The VirS/VirR two-component system regulates the anaerobic cytotoxicity, intestinal pathogenicity, and enterotoxemic lethality of Clostridium perfringens type C isolate CN3685. MBio 2011, 2. e00338-00310.
71. Mani N., Lyras D., Barroso L., Howarth P., Wilkins T., Rood J.I., Sonenshein A.L., Dupuy B. Environmental response and autoregulation of Clostridiium difficile TxeR, a sigma factor for toxin gene expression. J. Bacteriol. 2002, 184:5971-5978.
72. Marshall K.M., Bradshaw M., Pellet S., Johnson E.A. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. Biochem. Biophys. Res. Commun. 2007, 361:49-54.
73. Marvaud J.C., Eisel U., Binz T., Niemann H., Popoff M.R. tetR is a positive regulator of the Tetanus toxin gene in Clostridium tetani and is homologous to botR. Infect. Immun. 1998, 66:5698-5702.
74. Marvaud J.C., Gibert M., Inoue K., Fujinaga V., Oguma K., Popoff M.R. botR is a positive regulator of botulinum neurotoxin and associated non toxic protein genes in Clostridium botulinum A. Mol. Microbiol. 1998, 29:1009-1018.
75. McCroskey L.M., Hatheway C.L., Fenicia L., Pasolini B., Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J. Clin. Microbiol. 1986, 23:201-202.
76. McCroskey L.M., Hatheway C.L., Woodruff B.A., Greenberg J.A., Jurgenson P. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult. J. Clin. Microbiol. 1991, 29:2618-2620.
77. Montal M. Botulinum neurotoxin: a marvel of protein Design. Annu. Rev. Biochem. 2010, 79:591-617.
78. Nakamura S., Okado I., Abe T., Nishida S. Taxonomy of Clostridium tetani and related species. J. Gen. Microbiol. 1979, 113:29-35.
79. Nakamura S., Serikawa T., Yamakawa K., Nishida S., Kozaki S., Sakaguchi S. Sporulation and C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin. Microbiol. Immunol. 1978, 22:591-596.
80. Narberhaus F., Waldminghaus T., Chowdhury S. RNA thermometers. FEMS Microbiol. Rev. 2006, 30:3-16.
81. Novick R.P., Geisinger E. Quorum sensing in staphylococci. Annu. Rev. Genet. 2008, 42:541-564.
82. Ohtani K., Hayashi H., Shimizu T. The luxS gene is involved in cell-cell signalling for toxin production in Clostridium perfringens. Mol. Microbiol. 2002, 44:171-179.
83. Ohtani K., Hirakawa H., Tashiro K., Yoshizawa S., Kuhara S., Shimizu T. Identification of a two-component VirR/VirS regulon in Clostridium perfringens. Anaerobe 2009, 16:258-264.
84. Ohtani K., Kawsar H.I., Okumura K., Hayashi H., Shimizu T. The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens strain 13. FEMS Microbiol. Lett. 2003, 222:137-141.
85. Okumura K., Ohtani K., Hayashi H., Shimizu T. Characterization of genes regulated directly by the VirR/VirS system in Clostridium perfringens. J. Bacteriol. 2008, 190:7719-7727.
86. Patterson-Curtis S.I., Johnson E.A. Regulation of neurotoxin and protease formation in Clostridium botulinum Okra B and Hall by arginine. Appl. Environ. Microbiol. 1989, 55:1544-1548.
87. Popoff M.R., Marvaud J.C. Structural and genomic features of clostridial neurotoxins. The Comprehensive Sourcebook of Bacterial Protein Toxins 1999, 174-201. Academic Press, London. second ed. J.E. Alouf, J.H. Freer (Eds.).
88. Porfirio Z., Prado S.M., Vancetto M.D.C., Fratelli F., Alves E.W., Raw I., Fernandes B.L., Camargo A.C.M., Lebrun I. Specific peptides of casein pancreatic digestion enhance the production of tetanus toxin. J. Appl. Microbiol. 1997, 83:678-684.
89. Poulain B., Popoff M.R., Molgo J. How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action. Botulinum J. 2008, 1:14-87.
90. Poulain B., Stiles B.G., Popoff M.R., Molgó J. Attack of the nervous system by clostridial toxins: physical findings, cellular and molecular actions. The Sourcebook of Bacterial Protein Toxins 2006, 348-389. Elsevier, Academic Press, Amsterdam. third ed. J.E. Alouf, M.R. Popoff (Eds.).
91. Raffestin S., Dupuy B., Marvaud J.C., Popoff M.R. BotR/A and TetR are alternative RNA polymerase sigma factors controlling the expression of the neurotoxin and associated protein genes in Clostridium botulinum type A and Clostridium tetani. Mol. Microbiol. 2005, 55:235-249.
92. Rao S., Starr R.L., Morris M.G., Lin W.J. Variations in expression and release of botulinum neurotoxin in Clostridium botulinum type A strains. Foodborne Pathog. Dis. 2007, 4:201-207.
93. Raphael B.H., Choudoir M.J., Luquez C., Fernandez R., Maslanka S.E. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl. Environ. Microbiol. 2010, 76:4805-4812.
94. Raphael B.H., Lautenschlager M., Kalb S.R., de Jong L.I., Frace M., Luquez C., Barr J.R., Fernandez R.A., Maslanka S.E. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol. 2012, 12:245.
95. Rodriguez Jovita M., Collins M.D., East A.K. Gene organization and sequence determination of the two botulinum neurotoxin gene clusters in Clostridium botulinum type A(B) strain NCTC 2916. Curr. Microbiol. 1998, 36:226-231.
96. Sakaguchi G., Sakaguchi S., kozaki S., Takahashi C. Purification and some properties of Clostridium type Ab toxin. FEMS Microbiol. Lett. 1986, 33:23-29.
97. Santos-Buelga J., Collins M.D., East A.K. Characterization of the genes encoding the botulinum neurotoxin complex in a strain of Clostridium botulinum producing type B and F neurotoxins. Cur. Microbiol. 1998, 37:312-318.
98. Schantz E.J., Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol. Rev. 1992, 56:80-99.
99. Sebaihia M., Peck M.W., Minton N.P., Thomson N.R., Holden M.T., Mitchell W.J., Carter A.T., Bentley S.D., Mason D.R., Crossman L., Paul C.J., Ivens A., Wells-Bennik M.H., Davis I.J., Cerdeno-Tarraga A.M., Churcher C., Quail M.A., Chillingworth T., Feltwell T., Fraser A., Goodhead I., Hance Z., Jagels K., Larke N., Maddison M., Moule S., Mungall K., Norbertczak H., Rabbinowitsch E., Sanders M., Simmonds M., White B., Whithead S., Parkhill J. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res. 2007, 17:1082-1092.
100. Shimizu T., Yaguchi H., Ohtani K., Banu S., Hayashi H. Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol. Microbiol. 2002, 43:257-265.
101. Skarin H., Hafstrom T., Westerberg J., Segerman B. Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics 2011, 12:185.
102. Skarin H., Segerman B. Horizontal gene transfer of toxin genes in Clostridium botulinum: involvement of mobile elements and plasmids. Mob Genet. Elem. 2011, 1:213-215.
103. Smith L.D.S. Clostridium tetani. The Pathogenic Anaerobic Bacteria 1975, 177-201. Charles C. Thomas Publisher, Springfield Ill. L.D.S. Smith (Ed.).
104. Smith T.J., Hill K.K., Foley B.T., Detter J.C., Munk A.C., Bruce D.C., Doggett N.A., Smith L.A., Marks J.D., Xie G., Brettin T.S. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids. PLoS ONE 2007, 2:e1271.
105. Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.L., Tepp W.H., Bradshaw M., Johnson E.A., Smith L.A., Marks J.D. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect. Immun. 2005, 73:5450-5457.
106. Sorek R., Kunin V., Hugenholtz P. CRISPR-a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat. Rev. Microbiol. 2008, 6:181-186.
107. Strom M.S., Eklund M.W., Poysky F.T. Plasmids in Clostridium botulinum and related species. Appl. Environ. Microbiol. 1984, 48:956-963.
108. Suen J.C., Hatheway C.L., Steigerwalt A.G., Brenner D.J. Clostridium argentinense sp. nov.: a genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int. J. Syst. Bacteriol. 1988, 38:375-381.
109. Thomason M.K., Storz G. Bacterial antisense RNAs: how many are there, and what are they doing?. Annu. Rev. Genet. 2010, 44:167-188.
110. Toledo-Arana A., Repoila F., Cossart P. Small noncoding RNAs controlling pathogenesis. Curr. Opin. Microbiol. 2007, 10:182-188.
111. Waters C.M., Bassler B.L. Quorum sensing: cell-to-cell communication in bacteria. Annu. Rev. Cell Dev. Biol. 2005, 21:319-346.
112. Weickert M.J., Chambliss G.H., Sugiyama H. Production of toxin by Clostridium botulinum type A strains cured of plasmids. Appl. Environ. Microbiol. 1986, 51:52-56.
113. Wilde E., Hippe H., Tosunoglu N., Schallehn G., Herwig K., Gottschalk G. Clostridium tetanomorphum sp. nov., nom rev. Int. J. SysT. Bacteriol. 1989, 39:127-134.
114. Yamakawa K., Karasawa T., Ohta T., Hayashi H., Nakamura S. Inhibition of enhanced toxin production by Clostridium difficile in biotin-limited conditions. J. Med. Microbiol. 1998, 47:767-771.
115. Yang G.H., Rhee S.D., Jung H.H., Yang K.H. Organization and nucleotide sequence of genes for hemagglutinin components of Clostridium botulinum type B progenitor toxin. Biochem. Mol. Biol. Int. 1996, 39:1141-1146.
116. Zhang Z., Korkeala H., Dahlsten E., Sahala E., Heap J.T., Minton N.P., Lindstrom M. Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502. PLoS Pathog. 2013, 9:e1003252. doi:1003210.1001371/journal.ppat.1003252, (Epub 1002013 Mar 1003228).
117. Zhao L., Montville T.J., Schaffner D.W. Evidence for quorum sensing in Clostridium botulinum 56A. Lett. Appl. Microbiol. 2006, 42:54-58.